Free tool
Oncology stocks
We cover 55 companies grouped under the Oncology theme. The median market value in the group is $679.77M. Across the group, the median move over the past trading day is +2.78%. 66% of the 53 with a 200-day average trade above it. Price change over the past year runs from −18.8% to +210.5% across the middle 80 percent of the group, with a median of +55.4%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
55 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $371.70B | Mega cap | +88.17% | Oct 29, 2026 |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +7.60% | Oct 30, 2026 |
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% | Nov 5, 2026 |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +14.76% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +800.59% | Nov 5, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.81B | Small cap | +144.52% | Nov 4, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% | Nov 13, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +27.20% | Nov 2, 2026 |
| BCAX | Bicara Therapeutics Inc. | $1.63B | Small cap | +117.14% | Nov 10, 2026 |
| AVBP | ArriVent BioPharma, Inc. | $1.55B | Small cap | +62.02% | Nov 16, 2026 |
| REPL | Replimune Group, Inc. | $1.49B | Small cap | +187.80% | Nov 5, 2026 |
| AKTS | Aktis Oncology, Inc. | $1.48B | Small cap | +19.15% | Nov 12, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% | Nov 5, 2026 |
| IMTX | Immatics N.V. | $1.26B | Small cap | +76.67% | Nov 17, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.24B | Small cap | +217.21% | Nov 5, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.16% | Nov 3, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% | Nov 5, 2026 |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% | Nov 3, 2026 |
| CADL | Candel Therapeutics, Inc. | $1.04B | Small cap | +138.18% | Nov 12, 2026 |
| GERN | Geron Corporation | $995.83M | Small cap | +9.15% | Nov 4, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $954.60M | Small cap | +95.17% | Nov 9, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +14.75% | Nov 3, 2026 |
| AURA | Aura Biosciences, Inc. | $810.97M | Small cap | +19.94% | Nov 12, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% | Nov 3, 2026 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −3.50% | Nov 11, 2026 |
| MNPR | Monopar Therapeutics Inc. | $747.47M | Small cap | +264.30% | Nov 12, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $734.32M | Small cap | +68.50% | Nov 5, 2026 |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −16.33% | Nov 12, 2026 |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −21.16% | Nov 3, 2026 |
| SGMT | Sagimet Biosciences Inc. | $639.61M | Small cap | +45.34% | Nov 12, 2026 |
| ARVN | Arvinas, Inc. | $610.71M | Small cap | +28.34% | Nov 4, 2026 |
| DCTH | Delcath Systems, Inc. | $587.10M | Small cap | +55.37% | Nov 3, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $524.86M | Small cap | +418.90% | Nov 11, 2026 |
| CCCC | C4 Therapeutics, Inc. | $516.71M | Small cap | +66.01% | Nov 5, 2026 |
| PBYI | Puma Biotechnology, Inc. | $470.77M | Small cap | +86.77% | Nov 5, 2026 |
| CMPX | Compass Therapeutics, Inc. | $455.62M | Small cap | −16.23% | Nov 5, 2026 |
| FENC | Fennec Pharmaceuticals Inc. | $410.64M | Small cap | +35.38% | Nov 12, 2026 |
| FHTX | Foghorn Therapeutics Inc. | $406.79M | Small cap | +30.48% | Nov 5, 2026 |
| AGEN | Agenus Inc. | $376.28M | Small cap | +90.43% | Nov 5, 2026 |
| CATX | Perspective Therapeutics, Inc. | $375.56M | Small cap | −4.91% | Nov 9, 2026 |
| BCYC | Bicycle Therapeutics plc | $306.47M | Small cap | −38.34% | Oct 29, 2026 |
| WHWK | Whitehawk Therapeutics, Inc. | $278.20M | Small cap | +198.82% | Nov 5, 2026 |
| ALXO | ALX Oncology Holdings Inc. | $276.55M | Small cap | +81.82% | Nov 6, 2026 |
| MGNX | MacroGenics, Inc. Common Stock | $265.63M | Small cap | +154.27% | Nov 12, 2026 |
| GLSI | Greenwich LifeSciences, Inc. | $258.04M | Small cap | +56.35% | Nov 12, 2026 |
| PYXS | Pyxis Oncology, Inc. | $255.23M | Small cap | +120.14% | Nov 2, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +1.34% | Sep 17, 2026 |
| TARA | Protara Therapeutics, Inc. | $234.61M | Small cap | +30.16% | Nov 10, 2026 |
| CHRS | Coherus Oncology, Inc. | $211.67M | Small cap | +17.09% | Nov 5, 2026 |
| ADCT | ADC Therapeutics SA | $132.77M | Small cap | −66.34% | Nov 10, 2026 |
| HURA | TuHURA Biosciences, Inc. | $130.00M | Small cap | −30.85% | Nov 13, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | $123.81M | Small cap | −21.95% | Nov 5, 2026 |
| ANIX | Anixa Biosciences, Inc. | $123.16M | Small cap | +22.00% | Sep 9, 2026 |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −18.72% | Nov 12, 2026 |
| ONCY | Oncolytics Biotech Inc. | $109.84M | Small cap | −12.99% | Nov 16, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.